CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment of previously untreated patients with chronic HCV genotype 1 infection with Boceprevir (BOC) in German real-life: High efficacy in patients with early virologic response
DOI 10.1055/s-0034-1386298
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthoeft, A Herrmann, M Hoesl, U Naumann, T Dahhan, D Hartmann, B Dreher, M Bilzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: The achievement of early virologic response (EVR) during triple therapy of chronic HCV genotype 1 infection with boceprevir (BOC) was identified as predictor of high SVR rates of up to 90% and as predictor to shorten treatment to 24 weeks. This interim analysis of the NOVUS observational study aimed to investigate EVR during BOC triple therapy in German real-life and to identify factors associated with E…
Zitieren
Zitierempfehlung
P Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthoeft, A Herrmann, M Hoesl, U Naumann, T Dahhan, D Hartmann, B Dreher, M Bilzer (2014) Treatment of previously untreated patients with chronic HCV genotype 1 infection with Boceprevir (BOC) in German real-life: High efficacy in patients with early virologic response. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0034-1386298
Mit CareLit weiterarbeiten